The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback